Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of a New MiraLax® Dose Formulation For Use in Constipated Children

NCT00319670 is registered in ClinicalTrials.gov with Braintree Laboratories as lead sponsor.

NCT NCT00319670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00319670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of a New MiraLax® Dose Formulation For Use in Constipated Children
Lead sponsor
Braintree Laboratories
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2006
Completion date
Not reported
Enrollment
25
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

constipation